Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 95.55B | 98.72B | 103.88B | 96.93B | 81.73B | 74.85B |
Gross Profit | 26.19B | 27.37B | 26.34B | 24.47B | 23.27B | 16.99B |
EBITDA | 13.62B | 14.61B | 14.78B | 12.28B | 13.82B | 10.23B |
Net Income | 5.37B | 6.47B | 6.39B | 4.47B | 7.33B | 4.30B |
Balance Sheet | ||||||
Total Assets | 111.38B | 119.41B | 111.90B | 110.92B | 99.63B | 90.56B |
Cash, Cash Equivalents and Short-Term Investments | 11.37B | 11.09B | 13.32B | 11.22B | 13.66B | 14.64B |
Total Debt | 0.00 | 20.04B | 21.69B | 21.27B | 19.21B | 17.82B |
Total Liabilities | 55.99B | 57.44B | 56.95B | 56.88B | 54.26B | 54.84B |
Stockholders Equity | 53.16B | 59.65B | 52.74B | 51.93B | 43.65B | 34.31B |
Cash Flow | ||||||
Free Cash Flow | 5.44B | 5.11B | 8.02B | 428.00M | 1.36B | 4.89B |
Operating Cash Flow | 10.65B | 10.79B | 13.78B | 5.64B | 5.25B | 8.27B |
Investing Cash Flow | -2.85B | -5.60B | -5.87B | -5.35B | -3.15B | -3.01B |
Financing Cash Flow | -4.85B | -7.57B | -4.51B | -3.40B | -3.51B | 2.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $11.42B | 22.41 | 9.46% | 3.14% | -2.49% | -4.87% | |
78 Outperform | $12.56B | 49.40 | 8.56% | ― | 5.48% | 16.88% | |
78 Outperform | $16.94B | 17.31 | 18.18% | 2.65% | -0.76% | -2.62% | |
78 Outperform | $13.29B | 27.08 | 37.35% | 1.24% | 0.24% | 0.05% | |
75 Outperform | $5.35B | 17.49 | 10.52% | 1.82% | -2.01% | -9.95% | |
69 Neutral | $11.80B | 24.17 | 5.38% | 4.23% | -2.71% | ― | |
63 Neutral | $10.76B | 16.24 | 7.41% | 2.07% | 2.60% | -16.34% |